Rotavirus vaccine effectiveness stratified by national-level characteristics: an introduction to the 24-country MNSSTER-V Project, 2007-2023.
Burnett E, Umana J, Anwari P, Mujuru HA, Groome MJ, Van Trang N, Iniguez V, Gheorghita S, Sahakyan G, Nazurdinov A, Michael F, Mandomando I, Desormeaux AM, Eraliev U, Enweronu-Laryea C, Nalunkuma C, Bonkoungou I, Muhsen K, Luhata Lungayo C, Omore R, Goldfarb DM, Robinson AL, McCracken J, Uwimana J, N'Zue K, Rey-Benito G, Weldegebriel G, Mwenda JM, Parashar UD, Tate JE; Multi-national subpopulations study to evaluate rotavirus vaccines (MNSSTER-V) project working group.
Burnett E, et al.
J Infect Dis. 2024 Nov 28:jiae597. doi: 10.1093/infdis/jiae597. Online ahead of print.
J Infect Dis. 2024.
PMID: 39607893